HomeInsightsEPS

Sotac Pharmaceuticals Ltd EPS

Sotac Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

()

stocks purchased

2.4 K

Stocks Traded

()

Last Updated on: Nov 08, 2024

Image

Sotac Pharmaceuticals Ltd

NSE: SotacPharma.

EPS

₹ 4.16

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Sotac Pharmaceuticals Ltd is ₹ 4.16 as of 07 Nov 24.
  • The Earning per Share of Sotac Pharmaceuticals Ltd changed from ₹ 2.33 to ₹ 0.42 over 9 quarters. This represents a CAGR of -53.30% .

Historical Earning per Share of Sotac Pharmaceuticals Ltd

No data available

* All values are in

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Sotac Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024122
06 Nov 2024116.2
04 Nov 2024118.75
31 Oct 2024125
30 Oct 2024123.5
25 Oct 2024130
23 Oct 2024136.8
21 Oct 2024144
11 Oct 2024137.2
10 Oct 2024137.2

SWOT Analysis Of Sotac Pharmaceuticals Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sotac Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sotac Pharmaceuticals Ltd

Market Value

135

Asset Value

62

1.2 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sotac Pharmaceuticals Ltd News Hub

News

Sotac Pharmaceuticals schedules board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O...

Read more

26 Oct 202410:22

News

Sotac Pharmaceuticals AGM scheduled

Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

30 Aug 202416:55

News

Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

09 Aug 202416:36

News

Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 M...

Read more

10 May 202412:07

News

Sotac Pharmaceuticals to discuss results

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 Fe...

Read more

22 Jan 202417:40

News

Sotac Pharmaceuticals to announce Quarterly Result

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 No...

Read more

01 Nov 202316:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sotac Pharmaceuticals Ltd

What is the EPS of Sotac Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Sotac Pharmaceuticals Ltd is 4.16. An EPS is the amount of net income attributed to each share of a common stock.

How is Sotac Pharmaceuticals Ltd EPS calculated?

The EPS of Sotac Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sotac Pharmaceuticals Ltd report its EPS?

Sotac Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sotac Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Sotac Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sotac Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Sotac Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*